NCT00587847View on ClinicalTrials.gov

Campath Maintenance in Chronic Lymphocytic Leukemia

NATerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG

Campath

Campath 30 mg administered subcutaneously at varying intervals for up to 1 year

Trial Locations (1)

11040

Long Island Jewish Medical Center, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Northwell Health

OTHER